In Q42014, Hetlioz Sales Increase 15% Compared to Q32014
“2014 was a transformational year for Vanda with the Hetlioz launch in the US for the treatment of Non-24-Hour Sleep-Wake Disorder. We are impressed with the continued growth of HETLIOZ and are fortunate to be able to...
Read More